Deseret Mutual Benefit Administrators’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $302K | Hold |
575
| – | – | 0.14% | 95 |
|
|
2025
Q1 | $365K | Sell |
575
-46
| -7% | -$29.2K | 0.18% | 78 |
|
|
2024
Q4 | $442K | Buy |
621
+12
| +2% | +$8.55K | 0.22% | 65 |
|
|
2024
Q3 | $640K | Sell |
609
-13
| -2% | -$13.7K | 0.33% | 48 |
|
|
2024
Q2 | $654K | Sell |
622
-6
| -1% | -$6.31K | 0.3% | 51 |
|
|
2024
Q1 | $604K | Buy |
628
+6
| +1% | +$5.78K | 0.3% | 53 |
|
|
2023
Q4 | $546K | Sell |
622
-199
| -24% | -$175K | 0.32% | 54 |
|
|
2023
Q3 | $676K | Sell |
821
-55
| -6% | -$45.3K | 0.33% | 51 |
|
|
2023
Q2 | $629K | Buy |
876
+86
| +11% | +$61.8K | 0.24% | 57 |
|
|
2023
Q1 | $649K | Buy |
790
+76
| +11% | +$62.4K | 0.26% | 55 |
|
|
2022
Q4 | $515K | Sell |
714
-238
| -25% | -$172K | 0.21% | 65 |
|
|
2022
Q3 | $656K | Buy |
952
+112
| +13% | +$77.2K | 0.18% | 78 |
|
|
2022
Q2 | $497K | Buy |
840
+293
| +54% | +$173K | 0.11% | 123 |
|
|
2022
Q1 | $382K | Buy |
547
+259
| +90% | +$181K | 0.08% | 173 |
|
|
2021
Q4 | $182K | Buy |
288
+26
| +10% | +$16.4K | 0.03% | 282 |
|
|
2021
Q3 | $159K | Hold |
262
| – | – | 0.03% | 290 |
|
|
2021
Q2 | $146K | Buy |
+262
| New | +$146K | 0.04% | 267 |
|